Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
-1.71%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$109B
AUM Growth
+$5.35B
(+5.2%)
Cap. Flow
+$9.98B
Cap. Flow
% of AUM
9.19%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
1,617
New
23
Increased
851
Reduced
153
Closed
16
Top Buys
| 1 |
Apple
AAPL
|
+$621M |
| 2 |
Microsoft
MSFT
|
+$614M |
| 3 |
NVIDIA
NVDA
|
+$519M |
| 4 |
Amazon
AMZN
|
+$381M |
| 5 |
S&P Global
SPGI
|
+$341M |
Top Sells
| 1 |
Constellation Brands
STZ
|
+$346M |
| 2 |
Abbott
ABT
|
+$109M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$94.5M |
| 4 |
IQVIA
IQV
|
+$90.2M |
| 5 |
AutoZone
AZO
|
+$87.6M |
Sector Composition
| 1 | Technology | 29.63% |
| 2 | Financials | 15.95% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Novavax
NVAX
$1.29B
| $213K | ﹤0.01% |
33,169
+2,780
| +9% | +$17.8K |
|
952
Lufax Holding
LU
$2.62B
| $211K | ﹤0.01% |
70,969
+7,122
| +11% | +$21.2K |
|
953
Toronto Dominion Bank
TD
$129B
| $209K | ﹤0.01% |
3,489
+350
| +11% | +$21K |
|
954
Novartis
NVS
$248B
| $209K | ﹤0.01% |
1,874
+157
| +9% | +$17.5K |
|
955
Beam Therapeutics
BEAM
$2.06B
| $205K | ﹤0.01% |
10,492
+879
| +9% | +$17.2K |
|
956
Aspen Aerogels
ASPN
$549M
| $205K | ﹤0.01% |
32,034
-1,009
| -3% | -$6.45K |
|
957
Regenxbio
RGNX
$500M
| $198K | ﹤0.01% |
27,756
+2,326
| +9% | +$16.6K |
|
958
dLocal
DLO
$4.01B
| $197K | ﹤0.01% |
23,658
+2,375
| +11% | +$19.8K |
|
959
i3 Verticals
IIIV
$741M
| $196K | ﹤0.01% |
7,926
+796
| +11% | +$19.6K |
|
960
CRISPR Therapeutics
CRSP
$4.88B
| $195K | ﹤0.01% |
5,725
+473
| +9% | +$16.1K |
|
961
Paysafe
PSFE
$839M
| $193K | ﹤0.01% |
12,315
+1,237
| +11% | +$19.4K |
|
962
HealthEquity
HQY
$8.01B
| $191K | ﹤0.01% |
2,166
+192
| +10% | +$17K |
|
963
Ionis Pharmaceuticals
IONS
$10.3B
| $185K | ﹤0.01% |
6,135
+481
| +9% | +$14.5K |
|
964
Arrowhead Research
ARWR
$3.83B
| $184K | ﹤0.01% |
14,476
+1,195
| +9% | +$15.2K |
|
965
Avidity Biosciences
RNA
$6B
| $181K | ﹤0.01% |
6,135
+514
| +9% | +$15.2K |
|
966
LendingClub
LC
$1.89B
| $178K | ﹤0.01% |
17,230
+1,730
| +11% | +$17.9K |
|
967
Asana
ASAN
$3.29B
| $174K | ﹤0.01% |
11,953
-1,520
| -11% | -$22.1K |
|
968
FMC
FMC
$4.6B
| $174K | ﹤0.01% |
4,123
-87,519
| -96% | -$3.69M |
|
|
PSTL
969
Postal Realty Trust
PSTL
$392M
| $173K | ﹤0.01% |
12,102
| – | – |
|
970
Roivant Sciences
ROIV
$9.21B
| $173K | ﹤0.01% |
17,110
+1,434
| +9% | +$14.5K |
|
971
American Superconductor
AMSC
$2.25B
| $169K | ﹤0.01% |
9,294
-210
| -2% | -$3.81K |
|
972
Sarepta Therapeutics
SRPT
$1.85B
| $168K | ﹤0.01% |
2,638
+209
| +9% | +$13.3K |
|
973
Azenta
AZTA
$1.35B
| $168K | ﹤0.01% |
4,842
+396
| +9% | +$13.7K |
|
974
Riot Platforms
RIOT
$5.62B
| $167K | ﹤0.01% |
23,437
+2,353
| +11% | +$16.8K |
|
975
Dropbox
DBX
$8.42B
| $165K | ﹤0.01% |
6,183
-756
| -11% | -$20.2K |
|